Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2025)

Fennec Pharmaceuticals filings provide 5 years of Asset Utilization Ratio readings, the most recent being 0.75 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 18.59% to 0.75 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.75, a 18.59% decrease, with the full-year FY2025 number at 0.77, down 41.61% from a year prior.
  • Asset Utilization Ratio hit 0.75 in Q4 2025 for Fennec Pharmaceuticals, down from 0.82 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.94 in Q1 2024 to a low of 0.01 in Q1 2021.
  • Median Asset Utilization Ratio over the past 4 years was 0.74 (2024), compared with a mean of 0.63.
  • Biggest five-year swings in Asset Utilization Ratio: soared 1115.68% in 2024 and later dropped 27.69% in 2025.
  • Fennec Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2021, then skyrocketed by 13338.91% to 0.91 in 2023, then increased by 0.88% to 0.92 in 2024, then fell by 18.59% to 0.75 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.75 (Q4 2025), 0.82 (Q3 2025), and 0.73 (Q2 2025) per Business Quant data.